News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Geffken Daniel E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/03/2023 |
4
| Geffken Daniel E. (Interim CFO) has filed a Form 4 on CalciMedica, Inc.|
Txns:
| Granted 11,520 warrants
@ $6.6, valued at
$76k
Granted 5,760 warrants
@ $10.42, valued at
$60k
|
|
| 05/03/2023 |
3
| Geffken Daniel E. (Interim CFO) has filed a Form 3 on CalciMedica, Inc. |
| 07/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
4
| Geffken Daniel E. (INTERIM CFO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 50,000 shares
@ $0.72, valued at
$36k
|
|
| 10/12/2021 |
4
| Geffken Daniel E. (CFO) has filed a Form 4 on PHOENIX BIOTECH ACQUISITION CORP.|
Txns:
| Acquired 30,000 options to buy
@ $0 |
|
| 10/05/2021 |
3
| Geffken Daniel E. (CFO) has filed a Form 3 on PHOENIX BIOTECH ACQUISITION CORP. |
| 06/17/2021 |
4
| Geffken Daniel E. (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Granted 15,000 options to buy
@ $2.28, valued at
$34.2k
|
|
| 04/22/2021 |
4
| Geffken Daniel E. (CFO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.38, valued at
$238k
|
|
| 04/02/2021 |
3
| Geffken Daniel E. (CFO) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/27/2020 |
4
| Geffken Daniel E. (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Bought 2,069 shares
@ $7.25, valued at
$15k
Bought 2,069 warrants
@ $7.975, valued at
$16.5k
|
|
| 04/26/2019 |
4
| Geffken Daniel E. (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/|
Txns:
| Granted 60,000 options to buy
@ $4.32, valued at
$259.2k
|
|
| 04/26/2019 |
3
| Geffken Daniel E. (Director) has filed a Form 3 on WINDTREE THERAPEUTICS INC /DE/ |
|
|